Photo: Halfpoint Images/Getty Images
Whole-person healthcare technology company WellSky is partnering with automated clinical research registry platform uMed to allow patients to participate in national clinical studies from their homes.
WellSky provides software, analytics and services to providers, payers, health systems and community organizations, while uMed partners with life sciences and research companies, patients and healthcare providers to connect patients with medical research.
uMed's ACCESS Cohorts platform aims to help teams build datasets that leverage technology to combine clinical and patient-generated data.
WellSky's network of more than 10,000 home-based care organizations, combined with uMed's patient registry platform, will allow patients to access national clinical research registries remotely and participate in clinical studies from their home.
The companies say the collaboration enables the collection of high-quality, real-world clinical information from patients who want to participate in clinical research and helps providers improve the quality of their reporting and performance measurement.
"Access to participate in clinical research has historically been limited for many patients, particularly those not connected to major academic medical centers,” Bill Miller, chairman and CEO of WellSky, said in a statement.
"By integrating WellSky’s expansive provider network with uMed’s turnkey registry infrastructure, we are establishing a new framework for inclusive, patient-centered research that meets individuals where they are."
THE LARGER TREND
In October, WellSky announced a partnership with Suki, maker of an AI-enabled healthcare voice tool.
Through the partnership, Suki will power WellSky’s AI-powered ambient listening offering to assist with clinical documentation within the company’s EHR for specialty care settings, including behavioral health, long-term acute care and rehabilitation facilities.
Several companies focus on improving the clinical trial sector, including Medable, which offers Agent Studio, an AI-enabled offering the company said is purpose-built to help life sciences firms use agentic AI tailored for clinical trial monitoring.
Alleviate Health is an Andreessen Horowitz-backed AI-enabled patient recruitment company for clinical trials, which launched in October with $4.3 million in seed funding.
The North Carolina-based company provides human-in-the-loop AI agents that screen patients for clinical trial participation, engaging with them around the clock via SMS and voice, while also verifying eligibility and scheduling visits and calls.
